PBAC's latest decision on Medium chain triglycerides formula: Recommended with restriction (2016). Considered for Dietary management of conditions requiring a source of medium chain triglycerides in children aged 1-10 years with fat malabsorption due to liver disease, short gut syndrome, cystic fibrosis, or gastrointestinal disorders.
PBAC outcome
Recommended with restriction
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
3
first 2015
Submissions
3
2015 → 2016
Eligible population
Children aged 1-10 years with fat malabsorption due to liver disease, short gut syndrome, cystic fibrosis, or gastrointestinal disorders requiring a source of medium chain triglycerides.
Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Cost-minimisation
Primary endpoint
Cost-minimisation
Comparator
Peptamen Junior powder
Economic model
Cost-minimisation
ICER note
Cost-minimisation analysis; no ICER calculated. Submission stated the product should cost the same per kJ of energy as the comparator.
Submission history
Jul 2015: Recommended with restriction · Restricted
Nov 2015: Deferred · Restricted
Nov 2016: Recommended with restriction · Restricted